Inhibition of mitochondrial permeability transition at reperfusion improves functional recovery and mortality in mice.
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Introduction
Myocardial infarction remains the leading cause of cardiac death in western countries. Heart failure is an increasingly common outcome of myocardial infarction, and a frequent cause of cardiovascular morbidity and mortality (22, 40, 44) . Survival five years after the diagnosis of heart failure is poor, ranging as low as 25-35% (33) .
Infarct size is a major determinant of mortality (10) . Besides treatment of heart failure per se, initial limitation of infarct size appears in theory the best-suited strategy to prevent postischemic heart failure and improve survival.
Postconditioning might offer major hope to improve postinfarction outcome.
Zhao et al. reported that three episodes of 30 seconds of reperfusion / 30 seconds of ischemia performed immediately after a prolonged 60 minute ischemic insult in the dog heart dramatically attenuate irreversible myocardial injury (54) . This observation has now been confirmed in several experimental preparations, and more recently in man (4, 9, 32, 35, 38, 47) .
Since ischemic postconditioning by angioplasty cannot be proposed to all patients with ongoing acute myocardial infarction, identification of a pharmacological mimetic to postconditioning is obviously required. Potential molecular targets have already been identified along with signalling pathways involved in postconditioning, including adenosine A 2A or A 3 receptors, mitochondrial K
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At the end of the 24 hours reperfusion, the coronary artery was briefly reoccluded and 0.5 mg/kg Unisperse blue pigment (Ciba-Geigy ® , Hawthorne, NY)
was injected intravenously to delineate the in vivo area at risk, as previously described (23). With this technique, the previously nonischemic myocardium appears blue, whereas the previously ischemic myocardium (area at risk) remains unstained.
The heart was excised and cut into four to five one millimeter thick transverse slices, parallel to the atrioventricular groove. After removing right ventricular tissue, each heart slices were weighed. The basal surface of each slice was photographed for later measurement of the area at risk (AR). Each slice was then incubated for 15 minutes in a 1% solution of triphenyltetrazolium chloride at 34°C to differentiate infarcted (pale) from viable (brick red) myocardial area (49) . The slices were then rephotographed. Enlarged projections of these slices were traced for determination of the boundaries of the area at risk and area of necrosis. Extent of the area at risk and area of necrosis was quantified by computerized planimetry and corrected for the weight of the tissue slices.
Total weights of the area at risk (AR) and the area of necrosis (AN) were then calculated and expressed in grams and as percentage of total left ventricle (LV), or of the AR weight, respectively.
Preparation of isolated mitochondria
At the end of the 24 hour reperfusion period, hearts were excised while still beating, immediately placed in cold buffer, and area at risk myocardium harvested for mitochondria isolation. Preparation of mitochondria was adapted from a previously described procedure (23). All operations were carried out in a cold room at 4°C.
Myocardial area at risk biopsies (20-30mg) were placed in isolation buffer containing The in vitro effect of Debio-025 had so far only been assessed in rat brain mitochondria; we then addressed its ability to inhibit transition pore opening assessed using mitochondria isolated from sham hearts. We first performed an in vitro study to determine the capacity of Debio-025 (concentration ranging from 10 nM to 1µM, i.e. from no detectable effect to plateau effect) to inhibit mPTP opening in sham mice hearts: in this case, mitochondria were isolated from the whole sham left ventricle. Assessment of CRC was also performed after 24 hours of reperfusion in sham, control, postconditioned or Debio-025 mice. In all four groups, mitochondria were isolated from the area at risk within the anterior wall of the left ventricle. Care was taken to clearly identify, by visual inspection, the boundaries of the area at risk during ischemia; myocardium was harvested at least 1mm within the area at risk limits to avoid contamination by nonischemic myocardial tissue.
Recovery of LV contractile function
At the end of the 30 day period (i.e. just prior to euthanasia), echocardiography was performed under light intra-peritoneal anesthesia (ketamine 80 mg/kg, IP). Images were acquired using a 13-MHz linear-array transducer with a digital ultrasound system (Vivid 7, GE Medical Systems). Conventional measurements (LV end diastolic diameter (LVEDD) and end-systolic diameter (LVESD)) were obtained from gray-scale M-mode tracings at the level of the papillary muscles. LV ejection fraction (LVEF) was calculated from the 2D parasternal longaxis view by the prolate-ellipsoid method (18, 43) . After echocardiography, size of the
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Treatment by Debio-025
Debio-025 was a gift of Debiopharm SA (Lausanne, Switzerland). Debio-025 is a non-immunosuppressive cyclosporine, that inhibits cyclophilin D within the mitochondrial matrix, and has been shown in isolated rat brain mitochondria to be a potent inhibitor of mPTP opening (30) . Debio-025 was dissolved in a mixture of Solutol and 94%-ethanol (46) . Debio-025 was injected over three minutes into the caudal vein at a dose of 10 mg/kg, 5 min before coronary artery reperfusion.
Statistical Analysis
Comparison between groups was performed using one-way ANOVA. When a significant F value was obtained, means were compared using a Tukey's test.
Differences in the relationship between infarct size and area at risk were evaluated by analysis of covariance (ANCOVA) and post hoc Tukey's test, with infarct size as the dependent variable and area at risk as the covariant. Survival was analyzed using Kaplan-Meier curves, and differences among groups evaluated using Log rank test. All values are expressed as mean ± standard error (SEM). Statistical significance was defined as a value of p<0.05. 
Calcium Retention Capacity
In twenty one mice (5 sham, 6 control, 5 postconditioned, 5 Debio-025), CRC was assessed in mitochondria isolated at the end of the 24 hour reperfusion period.
In sham hearts, mitochondrial CRC averaged 271±32 nmoles Ca % in controls) ( Figure 6 ). These differences existed although heart rate was comparable among treated groups, and not different from that expected in normal unsedated mice, indicating that anesthesia was light and did not interfere with assessment of contractile function.
day survival
Fifty-seven mice were followed up for 30 days to address mortality following acute myocardial infarction: 20 control, 14 postconditioned, 18 Debio-025, and 5
sham. Two mice died during the surgical preparation (1 control, 1 postconditioned).
During the 30 day follow-up period, 11 mice died: 8 controls, 1 postconditioned, 2
Debio-025.
As depicted on the Kaplan-Meier curves (Figure 7 ), 30 days after AMI, the survival rate was significantly better in PostC and Debio-025 groups, with a mean value of 92% and 89%, versus 58 % in the control group (log-rank test, p < 0.05). hearts displayed similar enhanced calcium retention capacity. This is in agreement with a preliminary report from our group showing that postconditioning improved calcium retention capacity of isolated mitochondria together with increasing the concentration of total and free mitochondrial calcium (6) . These data further suggest that mitochondrial calcium concentration is likely not the only signal that regulate mPTP opening upon reperfusion. These results are in agreement with previous reports, suggesting that mitochondrial permeability transition plays a key role in lethal reperfusion injury and may be a good candidate for future pharmacological postconditioning in patients (27, 31, 36) . Because Debio-025 was administered five minutes before reflow, one might question whether it may also have limited ischemiainduced injury. This is however unlikely; previous studies using other inhibitors of transition pore opening administered only one minute before reperfusion showed comparable infarct size limitation (4, 5) . It might be questioned whether the increased CRC observed in the treated groups could simply be the consequence of more viable Whether pharmacological inhibition of mPTP opening might have unspecific side effects on LV remodelling cannot be ruled out. Yet, unlike CsA, that binds to the cytosolic cyclophilin A and acts on calcineurin-NFAT pathway, Debio-025 is a cyclophilin D inhibitor that does not act on calcineurin-NFAT pathway, and has no known action on cardiac hypertrophy that would influence cardiac remodelling (28) .
The role of other mechanisms that play a role in ischemia-reperfusion damage, including altered function of the sarcoplasmic reticulum function or spread of injury via gap junctions, cannot be ruled out (21, 42) .
Since postconditioning and Debio-025 treatments were performed at one single time point (i.e. at the time of reperfusion), and had comparable impact on lethal reperfusion injury, it appears likely that the observed limitation of LV dilatation and improvement of contractile function corresponds to an unspecific consequence of infarct size limitation (51). This is in agreement with clinical reports indicating that peak creatine kinase value, a surrogate marker for infarct size, is an independent predictor of LV remodelling (8).
Another major observation of the present study is that postconditioning and inhibition of the mitochondrial permeability transition pore by Debio-025 significantly reduced the mortality rate within the first 30 days after acute myocardial infarction.
The mechanism of this major outcome remains to be determined. Most deaths in the control group occurred during the first two days after reperfusion. This pattern is different from what is usually observed in permanent coronary artery ligation studies in mice, in which mortality incidence is more scattered over the first week after infarction (1, 20, 26) . In the mouse model of reperfused myocardial infarction, most early deaths may be due either to lethal ventricular arrhythmias or acute heart failure.
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The present study does not allow us to determine which of these two types of events were affected by Debio-025 and postconditioning. One cannot exclude that both treatments had anti-arrhythmic effects. Galagudza et al. and Halkos et al.
reported that ischemic postconditioning reduces the incidence of ventricular arrhythmias, although the benefit they reported was not statistically significant (19, 29) . Recently, Kloner et al. reported that postconditioning significantly inhibits reperfusion arrhythmias after a five minute ischemic insult in the rat heart (39).
Although it has recently been proposed that mitochondria may play a role in postischemic arrhythmias, inner membrane depolarization and activation of inner membrane anion channel (IMAC), rather than opening of the mitochondrial permeability transition pore, appeared involved (2). To our knowledge, there is no evidence in the literature that inhibition of mPTP opening might per se be antiarrhythmic. One may however speculate that inhibition of mPTP opening could attenuates myocardial stunning in the dog heart (54) . But, in that study, follow up of contractile function was limited to the first three hours after reperfusion, and, it cannot be ruled out that postconditioning or Debio-025 may limit acute LV dilatation, and prevent acute heart failure or even the related stretch-induced arrhythmias, within the first 48 hours after reperfusion. Further studies are needed to specifically address these important issues. 
Limitations of the study
